DE69129115D1 - Neues verfahren zur behandlung von depression - Google Patents

Neues verfahren zur behandlung von depression

Info

Publication number
DE69129115D1
DE69129115D1 DE69129115T DE69129115T DE69129115D1 DE 69129115 D1 DE69129115 D1 DE 69129115D1 DE 69129115 T DE69129115 T DE 69129115T DE 69129115 T DE69129115 T DE 69129115T DE 69129115 D1 DE69129115 D1 DE 69129115D1
Authority
DE
Germany
Prior art keywords
new method
treating depression
depression
treating
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69129115T
Other languages
English (en)
Other versions
DE69129115T2 (de
Inventor
Jan David Wallace
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of DE69129115D1 publication Critical patent/DE69129115D1/de
Application granted granted Critical
Publication of DE69129115T2 publication Critical patent/DE69129115T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69129115T 1990-10-12 1991-10-02 Neues verfahren zur behandlung von depression Expired - Fee Related DE69129115T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/596,270 US5025035A (en) 1990-10-12 1990-10-12 Method of treating depression
PCT/US1991/007330 WO1992006686A1 (en) 1990-10-12 1991-10-02 New method of treating depression

Publications (2)

Publication Number Publication Date
DE69129115D1 true DE69129115D1 (de) 1998-04-23
DE69129115T2 DE69129115T2 (de) 1998-07-16

Family

ID=24386662

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69129115T Expired - Fee Related DE69129115T2 (de) 1990-10-12 1991-10-02 Neues verfahren zur behandlung von depression

Country Status (11)

Country Link
US (1) US5025035A (de)
EP (1) EP0552240B1 (de)
JP (1) JP3192141B2 (de)
AT (1) ATE164065T1 (de)
CA (1) CA2092416A1 (de)
DE (1) DE69129115T2 (de)
DK (1) DK0552240T3 (de)
ES (1) ES2116298T3 (de)
GR (1) GR3026519T3 (de)
MX (1) MX9101526A (de)
WO (1) WO1992006686A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
US5510381A (en) * 1995-05-15 1996-04-23 Warner-Lambert Company Method of treatment of mania and bipolar disorder
SK283295B6 (sk) * 1996-03-14 2003-05-02 Warner-Lambert Company Substituovaná cyklická aminokyselina, jej použitie a farmaceutický prostriedok na jej báze
US6372792B1 (en) 1996-04-26 2002-04-16 Guy Chouinard Method for treating anxiety, anxiety disorders and insomnia
NZ332762A (en) 1996-07-24 2000-09-29 Warner Lambert Co Isobutylgaba and its derivatives for the treatment of pain
US6194459B1 (en) 1997-08-19 2001-02-27 Warner-Lambert Company Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants
US6294690B1 (en) 1997-10-07 2001-09-25 Warner-Lambert Company Process for preparing a cyclic amino acid anticonvulsant compound
CA2303244C (en) * 1997-10-27 2005-12-06 Warner-Lambert Company Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
NZ508015A (en) * 1998-05-15 2003-11-28 Warner Lambert Co Stabilized pharmaceutical preparations of gamma- aminobutyric acid derivatives and process for preparing the same
AU769038B2 (en) * 1998-05-15 2004-01-15 Warner-Lambert Company Llc Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
CA2370030C (en) * 1999-04-09 2007-08-14 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
JP2002541224A (ja) * 1999-04-09 2002-12-03 ワーナー−ランバート・カンパニー うつ病の治療のためのｇａｂａ類縁体と三環系化合物の組合わせ
AP2002002501A0 (en) * 1999-10-07 2002-06-30 Warner Lambert Co Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
ES2193008T3 (es) 2000-06-16 2004-07-01 Teva Pharmaceutical Industries Ltd. Gabapentina estable que contiene mas de 20 ppm de iones de cloro.
DK1423168T3 (da) 2001-09-03 2006-05-15 Newron Pharm Spa Farmaceutisk præparat omfattende gabapentin eller en analog deraf og et alfa-aminoamid og dets analgetiske anvendelse
US20030119908A1 (en) * 2001-12-21 2003-06-26 Zambon Group S.P.A. Stable gabapentin compositions
ITMI20012750A1 (it) 2001-12-21 2003-06-21 Procos Spa Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
US20050181071A1 (en) * 2004-02-18 2005-08-18 Binder Michael R. Method for the treatment of clinical depression
US20080096965A1 (en) * 2004-09-10 2008-04-24 Newron Pharmaceuticals S.P.A. (Halobenzyloxy) Benzylamino-Propanamides as Sodium and/or Calcium Channel Selective Modulators
WO2011151708A1 (en) 2010-06-01 2011-12-08 Rubicon Research Private Limited Gastroretentive dosage forms of gaba analogs
WO2015144825A1 (en) 2014-03-27 2015-10-01 Sanovel Ilac Sanayi Ve Ticaret A.S. Oral liquid pharmaceutical solution of gabapentin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US5084479A (en) * 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression

Also Published As

Publication number Publication date
DK0552240T3 (da) 1998-11-23
JPH06502148A (ja) 1994-03-10
CA2092416A1 (en) 1992-04-13
ATE164065T1 (de) 1998-04-15
EP0552240B1 (de) 1998-03-18
GR3026519T3 (en) 1998-07-31
EP0552240A1 (de) 1993-07-28
JP3192141B2 (ja) 2001-07-23
ES2116298T3 (es) 1998-07-16
EP0552240A4 (en) 1993-09-01
MX9101526A (es) 1992-06-05
WO1992006686A1 (en) 1992-04-30
DE69129115T2 (de) 1998-07-16
US5025035A (en) 1991-06-18

Similar Documents

Publication Publication Date Title
ATE164065T1 (de) Neues verfahren zur behandlung von depression
DE69635493D1 (de) Verfahren zur herstellung von l-aminosäuren
DE69434672D1 (de) Verfahren zur behandlung von hühnereiern
DE69214610D1 (de) Verfahren zur Behandlung von Erdgas
DE69318433D1 (de) Verfahren zur Behandlung von Verbrennungsabgasen
DE69130431D1 (de) Verfahren zur Herstellung von azlacton-funktionellen Michael-Addukten
DE69019074D1 (de) Verfahren zur Fraktionierung von Plasmaproteinen.
DE3888205D1 (de) Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.
DE69031447D1 (de) Verfahren zur Herstellung von MIS-Halbleiterbauelementen
DE69710422D1 (de) Verfahren zur Behandlung von Polyethern vor Hydrosilylation
DE69008820D1 (de) Verfahren zur Behandlung von Polymerisaten.
DE69102552D1 (de) Verfahren zur Behandlung von Fasermaterialien.
DE69129899D1 (de) Verfahren zur Herstellung von D-Alpha-Aminosäuren
DE69707033D1 (de) Verfahren zur Behandlung von Gasen die Organohalogenzusammensetzungen enthalten
DE69003009D1 (de) Verfahren zur Behandlung von Fasermaterialien.
DE69022269D1 (de) Verfahren zur thermischen Behandlung von Silizium.
ATE111439T1 (de) Verfahren zur herstellung von levodopa.
DE59106539D1 (de) Verfahren zur Oberflächenbehandlung von Bauteilen.
DE59209268D1 (de) Verfahren zur thermochemisch-thermischen behandlung von einsatzstählen
ATE70067T1 (de) Peptidaminoalkoholderivate, welche ein tetrasubstituiertes kohlenstoffatom besitzen, hemmungsstoffe von renin und proteasesaeuren, verfahren zur herstellung und pharmazeutische zusammensetzungen.
DE69313556D1 (de) Verfahren zur Herstellung von zyklischen Depsipeptiden
DE69607559D1 (de) Verfahren zur Behandlung von Phenolteer
DE69500138D1 (de) Verfahren zur dauerhaften Verformung von Keratinmaterialien
DE68903208D1 (de) Verfahren zur thermischen behandlung von laktoferrin.
DE69301936D1 (de) Verfahren zur Behandlung von Rauchgas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee